Atracare is now Offering Treatment for Patients with COVID: Bebtelovimab

  • This is a monoclonal antibody used to treat patients with COVID.
  • It is given as a slow IV injection over 30 seconds.  Then we monitor patients for 1 hour to ensure there is no reaction.
  • This medication is for anyone ≥12 years of age and weighing at least 40 kg.
  • The dosage is bebtelovimab 175 mg administered as a single intravenous injection over at least 30 seconds.
  • Administration of bebtelovimab is recommended to occur as soon as possible after positive results of direct SARS-CoV-2 viral testing and within 7 days of symptom onset.
  • This medication is best for patients who are at high risk for progression to severe COVID-19, including hospitalization or death, and
  • for whom alternative COVID-19 treatment options approved or authorized by FDA are not accessible or clinically appropriate.


From the FDA

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant. The EUA for bebtelovimab is for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms, which is about 88 pounds) with a positive COVID-19 test, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.

Bebtelovimab is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19. Treatment with bebtelovimab has not been studied in patients hospitalized due to COVID-19. Monoclonal antibodies, such as bebtelovimab, may be associated with worse clinical outcomes when administered to hospitalized patients with COVID-19 requiring high flow oxygen or mechanical ventilation.


FDA Fact Sheet> 

To get Bebtelovimab:

Contact us via text at 302-517-1385 and we can make arrangements for you to come into to get the treatment.  You can also email us at to arrange an injection.

0 New comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News and Clinic Information

We are your partner in health. Stay up to date with latest news and information.

Kelly Palekar, Winner of the Daisy Award

Last week, the Delaware Nursing Association had its inaugural Daisy event in Dover, Delaware, where they recognized two direct care nurses throughout the state. Kelly Palekar, our psychiatric nurse practitioner in the mental health department, was given a distinguished honor and recognition for her direct patient care skills.

Read More

Antibiotics Available in the Lobby at Atracare: Skip the Line at the Pharmacy

Atracare will become the first medical practice in Delaware to offer InstyMeds; a state-of-the-art medication dispensing technology. In many cases, InstyMeds will automate the need for multiple trips to get common medications by offering them on-site at their locations in Lewes and Ocean View. Learn what this means for you and your loved ones.

Read More

Navigating the Maze of Viral Illnesses This Fall: COVID-19, Influenza, and RSV

As we enter the fall season, it’s essential to stay informed about the viral illnesses that can affect our community. In Delaware, the changing weather, increased indoor gatherings, and a new school year can contribute to the spread of infectious illnesses including influenza (flu), COVID-19, and respiratory syncytial virus (RSV). 

Read More